wexpharma.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Crawl-delay: | ||
Meta Tags
| Title | A Breakthrough in Non-Opioid Pain Medication - WEX Pharmaceuticals Inc - Halneuron for Pain |
| Description | Non-OpioidPain WEX Pharmaceuticals Inc. (“WEX” or the “Company”), a biotechnology company developing HalneuronTM (Tetrodotoxin or TTX) for |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 199.167.200.110 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
wexpharma.com Valuation
|
US$1,736,790
Last updated: 2023-05-02 06:13:30
wexpharma.com has Semrush global rank of 6,094,177. wexpharma.com has an estimated worth of US$ 1,736,790, based on its estimated Ads revenue. wexpharma.com receives approximately 200,399 unique visitors each day. Its web server is located in United States, with IP address 199.167.200.110. According to SiteAdvisor, wexpharma.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$1,736,790 |
| Daily Ads Revenue | US$1,604 |
| Monthly Ads Revenue | US$48,096 |
| Yearly Ads Revenue | US$577,149 |
| Daily Unique Visitors | 13,360 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| wexpharma.com. | A | 14400 | IP: 199.167.200.110 |
| wexpharma.com. | NS | 300 | NS Record: sp2.domainpeople.com. |
| wexpharma.com. | NS | 300 | NS Record: sp1.domainpeople.com. |
| wexpharma.com. | MX | 14400 | MX Record: 5 wexpharma.com.snwlhosted.com. |
| wexpharma.com. | TXT | 14400 | TXT Record: v=spf1 a mx a:mail.wexpharma.com include:_spf.snwlhosted.com -all |
HtmlToTextCheckTime:2023-05-02 06:13:30
| About Technology About Halneuron Mechanism of Action About Pain Publications Media Clinical Trials Clinical Experience Ongoing Trials Physician Resources Investors Investment and Partnership Opportunities Corporate Presentation News & Media Contact Us 中文 Menu About Technology About Halneuron Mechanism of Action About Pain Publications Media Clinical Trials Clinical Experience Ongoing Trials Physician Resources Investors Investment and Partnership Opportunities Corporate Presentation News & Media Contact Us 中文 A breakthrough in Non-Opioid pain medication Non- Opioid Pain Relief WEX Pharmaceuticals Inc. is a biopharmaceutical company based in Vancouver, Canada and is developing a late-stage non-opioid analgesic, Halneuron®. Halneuron is a highly selective sodium channel blocker and represents a breakthrough in painkiller technology: No evidence of addiction, withdrawal symptoms and euphoria No evidence of tolerance build up over time Evidence of long duration of pain relief with minimal |
HTTP Headers
HTTP/1.1 301 Moved Permanently Connection: Keep-Alive Location: https://wexpharma.com/ Content-Type: text/html; charset=UTF-8 Date: Sun, 24 Oct 2021 17:22:39 GMT Server: LiteSpeed HTTP/2 200 content-type: text/html; charset=UTF-8 vary: Accept-Encoding, Cookie cache-control: max-age=3, must-revalidate date: Sun, 24 Oct 2021 17:22:39 GMT server: LiteSpeed alt-svc: quic=":443"; ma=2592000; v="43,46", h3-Q043=":443"; ma=2592000, h3-Q046=":443"; ma=2592000, h3-Q050=":443"; ma=2592000, h3-25=":443"; ma=2592000, h3-27=":443"; ma=2592000 |
wexpharma.com Whois Information
Domain Name: WEXPHARMA.COM Registry Domain ID: 111542866_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.domainpeople.com Registrar URL: http://www.domainpeople.com Updated Date: 2016-12-12T18:43:55Z Creation Date: 2004-02-09T19:57:40Z Registry Expiry Date: 2022-02-09T19:57:40Z Registrar: DomainPeople, Inc. Registrar IANA ID: 65 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: SP1.DOMAINPEOPLE.COM Name Server: SP2.DOMAINPEOPLE.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-12T23:50:40Z <<< |